HomeInsightsStock Comparison

Orchid Pharma Ltd vs Remus Pharmaceuticals Ltd Stock Comparison

Orchid Pharma Ltd vs Remus Pharmaceuticals Ltd Stock Comparison

Last Updated on: May 03, 2025

Key Highlights

  • The Latest Trading Price of Orchid Pharma Ltd is ₹ 794 as of 02 May 15:30.
  • The P/E Ratio of Orchid Pharma Ltd changed from 33.9 on March 2023 to 57.5 on March 2024 . This represents a CAGR of 30.24% over 2 yearsThe P/E Ratio of Remus Pharmaceuticals Ltd changed from 47.2 on March 2024 to 47.2 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Orchid Pharma Ltd changed from ₹ 10061 crore on March 2021 to ₹ 5301 crore on March 2024 . This represents a CAGR of -14.80% over 4 yearsThe Market Cap of Remus Pharmaceuticals Ltd changed from ₹ 1016 crore on March 2024 to ₹ 1016 crore on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The revenue of Orchid Pharma Ltd for the Dec '24 is ₹ 225.83 crore as compare to the Sep '24 revenue of ₹ 230.22 crore. This represent the decline of -1.91% The revenue of Remus Pharmaceuticals Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Orchid Pharma Ltd for the Dec '24 is ₹ 34.85 crore as compare to the Sep '24 ebitda of ₹ 37.85 crore. This represent the decline of -7.93% The ebitda of Remus Pharmaceuticals Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Orchid Pharma Ltd changed from ₹ 10.78 crore to ₹ 22.45 crore over 7 quarters. This represents a CAGR of 52.07% The net profit of Remus Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Orchid Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Remus Pharmaceuticals Ltd changed from 2.56 % on March 2023 to 3.5 % on March 2024 . This represents a CAGR of 16.93% over 2 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Orchid Pharma Ltd

  • Orchid Pharma Limited, is one of the leading pharmaceutical companies in India head quartered in Chennai and involved in development, manufacture and marketing of diverse bulk actives, formulations and nutraceuticals with exports spanning over 40 countries.
  • Orchid's world class manufacturing infrastructure include USFDA compliant API and Finished Dosage Form facilities at Chennai in India.
  • The Company has dedicated state-of-art and GLP compliant R&D infrastructure for Process Research, Drug Discovery and Pharmaceutical Research at Chennai. The Company has a portfolio of antibiotics, and veterinary products.
  • Antibiotics are life-saving drugs used to ght infections.
  • Different classes of antibiotics include Beta-lactam, Macrolide, Fluoroquinolone, Imidazoleetc.

About Remus Pharmaceuticals Ltd

  • Remus Pharmaceuticals Limited was originally incorporated as Remus Pharmaceuticals Private Limited' as a Private Limited Company, vide Certificate of Incorporation dated September 21, 2015, issued by the Assistant Registrar of Companies, Gujarat.
  • Subsequently, Company converted from a Private to Public and the name of the Company was changed to 'Remus Pharmaceuticals Limited' on January 06, 2023 by the Registrar of Companies, Ahmedabad. The Company is engaged in marketing & distribution of finished formulations of pharmaceutical drugs.
  • It deals in API (Active Pharmaceutical Ingredient), provide technical consultancy services to various distributors for preparation of reports on the dossiers of the products to be registered by them in various countries.
  • The Company deal in drug forms like Capsules, Cream, Eye Drops, Gel, Infusion, Inhalation, Inhaler, Injection, Nail Lacquer, Nasal Solution, Nasal Spray, Nebuliser, Ointment, Ophthalmic, Oral Gel, Oral Solution, Oral Suspension, Sachet, Suspension, Tablet.

Orchid Pharma Ltd News Hub

News

Orchid Pharma continues to be under rating watch with developing implications

Orchid Pharma announced that CARE has continued the rating CARE A-/ CARE A2 while maintain...

Read more

07 Mar 2025 13:33

News

Orchid Pharma's Alathur facility completes USFDA inspection

Orchid Pharma announced the successful completion of a surprise U.S. Food and Drug Adminis...

Read more

19 Feb 2025 19:36

News

Orchid Pharma to announce Quarterly Result

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 February ...

Read more

07 Feb 2025 15:56

News

Orchid Pharma to hold board meeting

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 11 November ...

Read more

06 Nov 2024 12:44

News

Orchid Pharma announces board meeting date

Orchid Pharma will hold a meeting of the Board of Directors of the Company on 12 August 20...

Read more

10 Aug 2024 12:49

News

Orchid Pharma to conduct AGM

Orchid Pharma announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

18 Jul 2024 20:35

Remus Pharmaceuticals Ltd News Hub

News

Board of Remus Pharmaceuticals recommends interim dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

09 Nov 2024 16:57

News

Remus Pharmaceuticals to convene board meeting

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

07 Nov 2024 10:21

News

Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company w...

Read more

31 Aug 2024 15:40

News

Remus Pharmaceuticals to table results

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 M...

Read more

10 May 2024 12:07

News

Remus Pharmaceuticals schedules EGM

Remus Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

24 Apr 2024 10:34

News

Remus Pharmaceuticals revises board meeting date

Remus Pharmaceuticals has revised the meeting of the Board of Directors which was schedule...

Read more

20 Apr 2024 15:16

SWOT Analysis Of Remus Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Orchid Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Remus Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Orchid Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Orchid Pharma Ltd and Remus Pharmaceuticals Ltd

Which company has a larger market capitalization, Orchid Pharma Ltd or Remus Pharmaceuticals Ltd?

Market cap of Orchid Pharma Ltd is 4,027 Cr while Market cap of Remus Pharmaceuticals Ltd is 1,167 Cr

What are the key factors driving the stock performance of Orchid Pharma Ltd and Remus Pharmaceuticals Ltd?

The stock performance of Orchid Pharma Ltd and Remus Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Orchid Pharma Ltd and Remus Pharmaceuticals Ltd?

As of May 3, 2025, the Orchid Pharma Ltd stock price is INR ₹794.0. On the other hand, Remus Pharmaceuticals Ltd stock price is INR ₹1981.0.

How do dividend payouts of Orchid Pharma Ltd and Remus Pharmaceuticals Ltd compare?

To compare the dividend payouts of Orchid Pharma Ltd and Remus Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions